Sumitomo Mitsui Trust Group Inc. reduced its stake in shares of Danaher Corporation (NYSE:DHR – Free Report) by 10.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,880,953 shares of the conglomerate’s stock after selling 222,495 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Danaher were worth $356,629,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also modified their holdings of the company. Elevated Capital Advisors LLC acquired a new position in Danaher during the 4th quarter worth $26,000. Hilton Head Capital Partners LLC bought a new position in Danaher in the 4th quarter valued at $27,000. Clal Insurance Enterprises Holdings Ltd increased its stake in shares of Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after buying an additional 53 shares during the period. JPL Wealth Management LLC bought a new stake in shares of Danaher during the third quarter worth $25,000. Finally, WFA of San Diego LLC bought a new stake in shares of Danaher during the second quarter worth $26,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Analyst Ratings Changes
Several equities analysts recently issued reports on DHR shares. Wells Fargo & Company decreased their price target on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 22nd. Argus dropped their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Friday, April 24th. Citigroup started coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price on the stock. Barclays lowered their price target on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Finally, Piper Sandler started coverage on shares of Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target for the company. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average price target of $233.52.
Danaher Stock Down 1.7%
Shares of Danaher stock opened at $190.90 on Thursday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The business has a fifty day simple moving average of $179.85 and a 200 day simple moving average of $199.68. The stock has a market cap of $135.11 billion, a PE ratio of 36.92, a price-to-earnings-growth ratio of 2.48 and a beta of 0.79.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the prior year, the company posted $1.88 earnings per share. The firm’s revenue was up 3.7% on a year-over-year basis. Research analysts predict that Danaher Corporation will post 8.44 EPS for the current year.
Danaher Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is currently 30.95%.
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
